Monte Paschi Falls, Aberdeen Rises, Argenx Plunges

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Shares of Monte Paschi fell as much as 6.1% in Milan to their lowest level since June after Italian constructions magnate Francesco Gaetano Caltagirone company’s board plans on rejecting Monte Paschi’s twin bids for Banco BPM and Banca Generali at the next shareholder meeting, according to an emailed statement.
- Aberdeen cut its stake in Standard Life by roughly half, as the UK wealth platform and asset manager looks to strengthen its balance sheet and fund growth.
- Argenx ended a late-stage trial of its best-selling medicine Vyvgart for a chronic autoimmune disorder after a monitoring panel said the study was unlikely to succeed.

See omnystudio.com/listener for privacy information.